PYMNTS.com February 9, 2024
TechBio firm Owkin selected Amazon Web Services as its primary cloud provider.
The firm will use AWS’ storage options, data security measures and computing capabilities to develop generative artificial intelligence applications and accelerate drug discovery, clinical trials and AI diagnostics, the companies said in a Friday (Feb. 9) press release.
Integrating Owkin’s research and development with AWS’ cloud infrastructure and services will help the TechBio firm unlock insights from patient data in hospitals and research centers, while preserving privacy and security, Owkin Co-founder and CEO Thomas Clozel said in the release.
“Beyond our cutting-edge technologies, our strongest asset is in the power of collective intelligence through collaboration,” Clozel said. “Teaming up with AWS enables us to harness the power, security...
Today's Sponsors
Today's Sponsor